• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

IMiG-MRI wins FDA clearance

Article

IMiG-MRI, the joint venture between Intermagnetics General ofLatham, NY, and Surrey Medical Imaging Systems of Surrey, U.K.,has received 510(k) clearance for its IMiG-MRI 0.15-tesla permanent-magnetscanner (SCAN 7/3/96). The Food and Drug

IMiG-MRI, the joint venture between Intermagnetics General ofLatham, NY, and Surrey Medical Imaging Systems of Surrey, U.K.,has received 510(k) clearance for its IMiG-MRI 0.15-tesla permanent-magnetscanner (SCAN 7/3/96). The Food and Drug Administration's actionwill enable IMiG-MRI to begin sales of the scanner in the U.S.as well as in several Asian countries, which have effectivelymade FDA clearance a requirement for marketing, according to IMiG-MRIgeneral manager Paul Domigan.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.